HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jason H Gill Selected Research

Membrane-Associated Matrix Metalloproteinases

2/2014Development of novel tumor-targeted theranostic nanoparticles activated by membrane-type matrix metalloproteinases for combined cancer magnetic resonance imaging and therapy.
9/2010Development of a novel tumor-targeted vascular disrupting agent activated by membrane-type matrix metalloproteinases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jason H Gill Research Topics

Disease

15Neoplasms (Cancer)
10/2019 - 06/2003
3Urinary Bladder Neoplasms (Bladder Cancer)
01/2013 - 05/2004
2Neoplasm Metastasis (Metastasis)
01/2017 - 04/2005
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2016 - 11/2004
2Necrosis
02/2014 - 09/2010
2Transitional Cell Carcinoma
01/2013 - 04/2005
2Colonic Neoplasms (Colon Cancer)
11/2004 - 06/2003
1Infections
05/2020
1Glioma (Gliomas)
01/2017
1Breast Neoplasms (Breast Cancer)
02/2014
1Carcinogenesis
04/2005
1Obesity
12/2004
1Lung Neoplasms (Lung Cancer)
11/2004
1Adenocarcinoma
06/2003

Drug/Important Bio-Agent (IBA)

6Pharmaceutical PreparationsIBA
05/2020 - 06/2003
5ProdrugsIBA
01/2017 - 11/2004
4Proteins (Proteins, Gene)FDA Link
04/2005 - 06/2003
3Matrix Metalloproteinases (MMPs)IBA
01/2017 - 11/2004
2Histone Deacetylase InhibitorsIBA
12/2016 - 10/2012
2ICT2588IBA
04/2014 - 09/2010
2Membrane-Associated Matrix MetalloproteinasesIBA
02/2014 - 09/2010
2Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
01/2013 - 06/2003
2ParaffinIBA
10/2004 - 05/2004
1AnthracyclinesIBA
01/2019
1VorinostatFDA Link
12/2016
1Indicators and Reagents (Reagents)IBA
04/2014
1von Willebrand FactorIBA
04/2014
1Peptides (Polypeptides)IBA
04/2014
1EnzymesIBA
02/2014
1Ferrosoferric Oxide (Magnetite)FDA Link
02/2014
1DuocarmycinsIBA
01/2013
1Cytotoxins (Cytolysins)IBA
01/2013
1(1- (chloromethyl)- 1,2- dihydropyrrolo(3,2- e)indol- 3(6H)- yl)(5- methoxy- 1H- indol- 2- yl)methanoneIBA
01/2013
1Cytochrome P-450 CYP1A1 (CYP1A1)IBA
01/2013
1Oxygen (Dioxygen)IBA
09/2010
1Doxorubicin (Adriamycin)FDA LinkGeneric
09/2010
1ICT 2552IBA
09/2010
1Matrix Metalloproteinase 14 (MT1-MMP)IBA
09/2010
1SodiumIBA
03/2008
1Phosphates (Orthophosphate)IBA
03/2008
1pancratistatinIBA
03/2008
1PPAR gammaIBA
12/2004
1Liposomes (Liposome)IBA
11/2004
1Secretory Phospholipases A2IBA
11/2004
1quinone (benzoquinone)IBA
10/2004
1NAD (NADH)IBA
10/2004
1DNA (Deoxyribonucleic Acid)IBA
10/2004
1Mitomycin (Mitomycin-C)FDA LinkGeneric
10/2004
1Formaldehyde (Formol)FDA Link
10/2004
1Oxidoreductases (Dehydrogenase)IBA
05/2004

Therapy/Procedure

6Therapeutics
10/2019 - 10/2004
1Drug Therapy (Chemotherapy)
01/2019
1Radiotherapy
01/2019
1Intravenous Administration
02/2014
1Precision Medicine
02/2014